Cell targeting by a generic receptor-targeted polymer nanocontainer platform

Journal of Controlled Release

Volumn 102, Issue 2, 2005, Pages 475-488

  Brož, Pavel ^a   Benito, Samantha M ^b   Saw, CheeLoong ^a,b   Burger, Peter ^a,b   Heider, Harald ^b   Pfisterer, Matthias ^a   Marsch, Stephan ^a   Meier, Wolfgang ^b   Hunziker, Patrick ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Drug delivery; Macrophage scavenger receptor A1; Polymer nanocontainer; Receptor targeting

Indexed keywords

CYTOTOXICITY; LIGANDS; NANOCONTAINERS;

BLOCK COPOLYMERS; CYTOLOGY; DIAGNOSIS; DISEASES; IMMUNOLOGY; MEDICAL APPLICATIONS; NANOTECHNOLOGY; PATIENT TREATMENT; POLYMERS; TOXICITY;

CELLS;

COPOLYMER; DRUG CARRIER; FLUORESCENT DYE; POLY(2 METHYLOXAZOLINE) B POLY(DIMETHYLSILOXANE) B POLY(2 METHYLOXAZOLINE); SCAVENGER RECEPTOR; SCAVENGER RECEPTOR A 1; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CELL LINE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RECEPTOR BINDING; FLUORESCENCE ANALYSIS; MACROPHAGE ACTIVATION; NANOTECHNOLOGY; NONHUMAN; POLYMER PRODUCTION; PRIORITY JOURNAL; TARGET CELL; TRANSGENE;

ANIMALS; BIOTIN; CERCOPITHECUS AETHIOPS; COS CELLS; DIMETHYLPOLYSILOXANES; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FLUORESCENT DYES; HUMANS; LIGANDS; PARTICLE SIZE; POLY G; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; SILICONES; STREPTAVIDIN;

EID: 11844289543     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.10.014     Document Type: Article

References (46)

1. S.A. Wickline, and G.M. Lanza Nanotechnology for molecular imaging and targeted therapy Circulation 107 2003 1092 1095
2. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318
3. M. Dobbelstein Viruses in therapy-royal road or dead end? Virus Res. 92 2003 219 221
4. B.A. Khaw, J. daSilva, I. Vural, J. Narula, and V.P. Torchilin Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes J. Control. Release 75 2001 199 210
5. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 47 2001 113 131
6. A.N. Lukyanov, and V.P. Torchilin Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs Adv. Drug Deliv. Rev. 56 2004 1273 1289
7. N. Nishiyama, S. Okazaki, H. Cabral, M. Miyamoto, Y. Kato, Y. Sugiyama, K. Nishio, Y. Matsumura, and K. Kataoka Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice Cancer Res. 63 2003 8977 8983
8. C. Dufes, J.M. Muller, W. Couet, J.C. Olivier, I.F. Uchegbu, and A.G. Schatzlein Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles Pharm. Res. 21 2004 101 107
9. V.P. Torchilin Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents ImmunoMethods 4 1994 244 258
10. V.P. Torchilin, A.N. Lukyanov, Z. Gao, and B. Papahadjopoulos-Sternberg Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs Proc. Natl. Acad. Sci. U. S. A. 100 2003 6039 6044
11. R. Savic, L. Luo, A. Eisenberg, and D. Maysinger Micellar nanocontainers distribute to defined cytoplasmic organelles Science 25 2003 615 618
12. P. Photos, B.M. Discher, L. Bacakova, F.S. Bates, and D.E. Discher Polymersomes in vivo: increased stealth with both PEG density and molecular weight J. Control. Release 90 2003 323 334
13. S. Faraasen, J. Voros, G. Csucs, M. Textor, H.P. Merkle, and E. Walter Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(l-lysine)-grafted poly(ethylene glycol) conjugate Pharm. Res. 20 2 2003 237 246
14. D.H. Munn, and A.L. Mellor Macrophages and the regulation of self-reactive T cells Curr. Pharm. Des. 9 2003 257 264
15. K. Takahashi, M. Takeya, and N. Sakashita Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals Med. Electron Microsc. 35 2002 179 203
16. T. Kamradt, and N.A. Mitchison Tolerance and autoimmunity N. Engl. J. Med. 344 2001 655 664
17. T.D. Tetley Macrophages and the pathogenesis of COPD Chest 121 5 Suppl. 2002 156 159
18. P.J. Barnes Chronic obstructive pulmonary disease N. Engl. J. Med. 343 2000 269 280
19. A. Davidson, and B. Diamond Autoimmune diseases N. Engl. J. Med. 345 2001 340 350
20. F.J. Geske, J. Monks, L. Lehman, and V.A. Fadok The role of the macrophage in apoptosis: hunter, gatherer, and regulator Int. J. Hematol. 76 2002 16 26
21. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
22. A. Graff, M. Sauer, P. Van Gelder, and W. Meier Virus-assisted loading of polymer nanocontainer Proc. Natl. Acad. Sci. U. S. A. 99 2002 5064 5068
23. T. Hirt, R.C. Baron, D. Lohmann, and W. Meier, PCT Int. Appl, 39 pp. ((Novartis, Switzerland; Novartis-Erfindungen Verwaltungsgesellschaft) Wo, 1999).
24. M.C. Woodle, C.M. Engbers, and S. Zalipsky New amphipathic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes Bioconjug. Chem. 5 1994 493 496
25. C. Nardin, T. Hirt, J. Leukel, and W. Meier Polymerized ABA triblock copolymer vesicles Langmuir 16 2000 1035 1041
26. B.M. Discher, Y.Y. Won, D.S. Ege, J.C. Lee, F.S. Bates, D.E. Discher, and D.A. Hammer Polymersomes: tough vesicles made from diblock copolymers Science 284 1999 1143 1146
27. C. Nardin, J. Widmer, M. Winterhalter, and W. Meier Amphiphilic block copolymer nanocontainers as bioreactors Eur. Phys. J., E Soft Matter 4 2001 403 410
28. W. Meier, C. Nardin, and M. Winterhalter Reconstitution of channel proteins in (polymerized) ABA triblock copolymer membranes Angew. Chem., Int. Ed. 39 2000 4599 4602
29. C. Nardin, S. Thoeni, J. Widmer, M. Winterhalter, and W. Meier Nanoreactors based on (polymerized) ABA-triblock copolymer vesicles Chem. Commun. 15 2000 1433 1434
30. A. Matsumoto, M. Naito, H. Itakura, S. Ikemoto, H. Asaoka, I. Hayakawa, H. Kanamori, H. Aburatani, F. Takaku, and H. Suzuki Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions Proc. Natl. Acad. Sci. U. S. A. 87 1990 9133 9137
31. Y. Yamada, T. Doi, T. Hamakubo, and T. Kodama Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system Cell. Mol. Life Sci. 54 1998 628 640
32. S. Tsuchiya, M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada Establishment and characterization of a human acute monocyte leukemia cell line (THP-1) Int. J. Cancer 26 1980 171 176
33. S. Tsuchiya, Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno, and K. Tada Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester Cancer Res. 42 1982 1530 1536
34. A.M. Pearson, M. Rich, and M. Krieger Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet- stabilized four-stranded helices J. Biol. Chem. 268 1993 3546 3554
35. S. Chiruvolu, S. Walker, J. Israelachvili, F.J. Schmitt, D. Leckband, and J.A. Zasadzinski Higher order self-assembly of vesicles by site-specific binding Science 264 1994 1753 1756
36. W. Meier Reversible cell aggregation induced by specific ligand-receptor coupling Langmuir 16 2000 1457 1459
37. H. Heider, S. Brenz Verca, S. Rusconi, and R. Asmis Comparison of lipid-mediated and adenoviral gene transfer in human monocyte-derived macrophages and COS-7 cells BioTechniques 28 2000 260 270
38. J.J. Rudiger, M. Roth, M.P. Bihl, B.C. Cornelius, M. Johnson, R. Ziesche, and L.H. Block Interaction of C/EBPalpha and the glucocorticoid receptor in vivo and in nontransformed human cells FASEB J. 16 2002 177 184
39. M. Roth, P.R. Johnson, J.J. Rudiger, G.G. King, Q. Ge, J.K. Burgess, G. Anderson, M. Tamm, and J.L. Black Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling Lancet 360 2002 1293 1299
40. V. Shirhatti, and G. Krishna A simple and sensitive method for monitoring drug-induced cell injury in cultured cells Anal. Biochem. 147 1985 410 418
41. R.W. Reyer Macrophage mobilization and morphology during lens regeneration from the iris epithelium in newts: studies with correlated scanning and transmission electron microscopy Am. J. Anat. 188 1990 345 365
42. R.E. Pagano, and J.N. Weinstein Interactions of liposomes with mammalian cells Annu. Rev. Biophys. Bioeng. 7 1978 435 468
43. 125I-asialofetuin by the perfused rat liver J. Biol. Chem. 255 1980 5971 5978
44. K. Takahashi, M. Takeya, N. Sakashita, M. Yoshimatsu, and K. Jinnouchi The role of macrophage scavenger receptors in atherogenesis Y. Shoenfeld D. Harats G. Wick Atherosclerosis and Autoimmunity 2001 Elsevier 29 40
45. H. Heider, and E.S. Wintergerst Mimicking phosphorylation at Ser-48 strongly reduces surface expression of human macrophage scavenger receptor class A: implications on cell motility FEBS Lett. 505 2001 185 190
46. J.T. Santini Jr., M.J. Cima, and R. Langer A controlled-release microchip Nature 397 1999 335 338